Vancouver, British Columbia--(Newsfile Corp. - March 11, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide investors with an update on the strategic value of the Holy Crap™ manufacturing facility and its role in supporting scalable growth, margin expansion, and broader market distribution across the Company's functional wellness portfolio.

The Holy Crap™ production facility operates under multiple recognized third-party certifications and regulatory registrations, including:

Certified Organic
Certified Kosher
Certified Non-GMO
Safe Food for Canadians (SFC) Licence
SQF – Fundamentals (Safe Quality Food Program)
FDA Registration

These certifications and regulatory credentials represent significant strategic assets that extend well beyond compliance. They provide Restart Life with an immediately scalable, premium-qualified manufacturing platform capable of supporting multiple brands within high-growth health and wellness channels while meeting both domestic and international food safety standards.

Margin Expansion Through Certified Infrastructure

By leveraging an already certified and licensed production environment, Restart Life reduces the time, cost, and operational complexity typically associated with obtaining Organic, Kosher, Non-GMO, and regulatory compliance certifications for new product lines.

Key margin benefits include:

• Elimination of redundant certification build-outs for future brands
• Reduced co-packing dependency and improved production control
• Ability to command premium pricing in organic and specialty channels
• Greater supply chain transparency and ingredient standardization
• Operational efficiencies as production volumes scale across multiple SKUs
• Immediate compliance with Canadian and U.S. regulatory frameworks through SFC licensing and FDA registration

As the Company expands BrainQ™, BrainBalls™, and Holy Crap™, the ability to operate within a single certified infrastructure enhances cost predictability and supports improved gross margin potential over time.

Expanded Retail and International Distribution Opportunities

Certified Organic, Kosher, Non-GMO, SQF food safety standards, and regulatory compliance through the Safe Food for Canadians Licence and FDA registration significantly broaden distribution access across:

• Natural and specialty grocery retailers
• Health-focused retail chains
• E-commerce marketplaces
• Institutional buyers requiring SQF-aligned food safety systems
• Export markets requiring recognized regulatory and food safety certifications

These credentials position Restart Life to pursue premium shelf placement and enter retail channels that prioritize certified and food-safe products as part of their merchandising standards.

Alignment with Science-Backed Product Development

The manufacturing platform is further strengthened by the Company's previously announced March 3, 2026 collaboration with the University of Manitoba and its Richardson Centre for Food Technology and Research (RCFTR).

This partnership supports ingredient validation, formulation optimization, stability analysis, and functional performance assessment across the Company's brands.

Together, the combination of:

• Certified and regulated production infrastructure
• Established consumer-facing brands
• University-led scientific studies

Scalable Platform for Future Brand Development

The Company intends to utilize its certified facility to:

• Optimize existing brands within certified frameworks
• Launch new functional food SKUs without structural certification delays
• Expand into adjacent wellness categories aligned with consumer demand
• Strengthen negotiating leverage with retailers and distributors

"Having certified Organic, Kosher, Non-GMO, and fully licensed food safety and regulatory capabilities in-house provides Restart Life with both strategic flexibility and economic leverage," said Steve Loutskou, CEO of Restart Life Sciences Corp. "When combined with our scientific collaboration at the University of Manitoba, we are building a platform designed to scale efficiently, protect margins, and expand distribution into premium wellness channels."

Restart Life Sciences would like to thank its shareholders for their ongoing support as the Company advances its mission and continues to execute on its strategy.

RSU Grant

In addition, the Company has granted an aggregate 1,000,000 restricted share units (the "RSUs") to consultants of the Company. The RSUs are valid for a two-year term and have been granted under and are governed by the terms of the Company's restricted share unit plan approved by shareholders at the Company's annual general meeting held on February 7, 2025.

About Restart Life Sciences Corp.
Restart Life Sciences Corp. is a Canadian-based life sciences company listed on the CSE. For more information about Restart Life, please visit the Company's website at www.restartlife.co.

Forward-Looking Statements
This news release contains statements that constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Restart Life Sciences' actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/288058

Source: Restart Life Sciences Corp.